They found that estrogen treatment induces DNA double-strand breaks in the target region of the estrogen receptor, and that the breaks are subsequently repaired by translocation, revealing a mechanistic origin of estrogen in cancer [31]. This evidence concerns the gene ESR1 and cancer.